Trial intelligence / Profile preview

Compound Staphylococcal Lysostaphin for Oral Mucositis Prophylaxis in Allo-HSCT

NCT06791746Phase 3Completed

Sponsor
Zhejiang University
Start
Jan 2020
Primary completion
Dec 2021
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of staphylolysin in oral mucositis (OM), sponsored by Zhejiang University. Started Jan 2020; status: completed.

02

Drugs

staphylolysin
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT06791746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06791746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call